摘要
目的探讨血清同型半胱氨酸在2型糖尿病肾病中的诊断价值。方法选取该院2018年7月—2019年8月诊治的500例2型糖尿病患者,将其中250例糖尿病合并肾病患者划分为观察组,另250例单纯糖尿病患者划分为对照组,对比两组患者血清中同型半胱氨酸水平。结果观察组同型半胱氨酸水平高于对照组(P<0.05);观察组阳性率高于对照组(P<0.05);观察组生化指标综合情况优越于对照组(P<0.05)。结论血清同型半胱氨酸在诊断2型糖尿病肾病中具有显著的应用效果,能够将糖尿病患者肾脏损伤程度通过血清同型半胱氨酸水平程度反应出来,为判定糖尿病病情程度提供可靠参照指标。
Objective To investigate the diagnostic value of serum homocysteine in type 2 diabetic nephropathy.Methods 500 patients with type 2 diabetes diagnosed and treated in our hospital from July 2018 to August 2019 were selected.250 patients with diabetes and nephropathy were divided into an observation group,and the other 250 patients with simple diabetes were divided into a control group.Serum homocysteine levels in patients were compared.Results The level of homocysteine in the observation group was higher than that in the control group(P<0.05);the positive rate in the observation group was higher than that in the control group(P<0.05);Conclusion Serum homocysteine has a significant application effect in diagnosing type 2 diabetic nephropathy.It can reflect the degree of kidney injury in diabetic patients through the level of serum homocysteine,which provides a reliable reference index for judging the degree of diabetes.
作者
郭自约
肖俊锐
GUO Zi-yue;XIAO Jun-rui(Shantou City Central Blood Station Guangdong,Shantou,515064;Shantou Traditional Chinese Medicine Hospital,Guangdong Shantou,515800)
出处
《糖尿病新世界》
2020年第12期172-173,178,共3页
Diabetes New World Magazine
